Skip to content

Study · In vitro (cell-free) · bovine and rat · 1990

1 result

Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.

Rorstad OP, Wanke I, Coy DH, Fournier A, Huang M

Molecular pharmacology1 Jun 1990Cited by 18 (Europe PMC)

PMID2163020 (opens in a new tab)DOI10.1016/s0026-895x(25)11046-8 (opens in a new tab)PepBankPUB-02163020
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cell-free)Activity measurement

    In vascular receptor binding studies, the full VIP molecule was necessary for full binding potency.

    In plain wordsIn lab tests, VIP needed its whole structure to bind blood vessel receptors with full strength.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    Not applicableBinding potency of full VIP molecule at the vascular receptor
    Study

    bovine, ratn: not reported in source

    vascular receptor preparations
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Integrity of the full VIP molecule was necessary for full potency of binding to the vascular receptor.
    1 context sentence
    Summary · context
    Tissue sources included bovine coronary artery, rat mesenteric artery, rat pituitary, rat brain synaptosomes, and rat liver.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.